-
公开(公告)号:US20230126568A1
公开(公告)日:2023-04-27
申请号:US18146198
申请日:2022-12-23
Applicant: FUJIFILM Corporation
Inventor: Yuki IMAKURA , Shinji MIMA , Izumi OGURA , Nao YAMAZAKI
IPC: C12N5/071
Abstract: An object of the present invention is to provide a method of producing an intestinal epithelial cell, which has a large number of cells per area and a high accuracy of kinetic prediction for a CYP3A4 substrate drug such as midazolam, by inducing the differentiation of a pluripotent stem cell, as well as the intestinal epithelial cell, a cell sheet, an evaluation method for a test substance, a screening kit for a test substance, and a cell preparation. According to the present invention, there is provided a production method for an intestinal epithelial cell, including a first differentiation step of differentiating a pluripotent stem cell into an intestinal stem cell, a proliferation step of proliferating the intestinal stem cell obtained in the differentiation step, and a second differentiation step of differentiating the intestinal stem cell obtained in the proliferation step into an intestinal epithelial cell, in which the proliferation step is a step of bringing the intestinal stem cell into a specific state.
-
公开(公告)号:US20180356399A1
公开(公告)日:2018-12-13
申请号:US15618151
申请日:2017-06-09
Applicant: FUJIFILM Corporation , The General Hospital Corporation
Inventor: Koju ITO , Chihaya KAKINUMA , Shinji MIMA , Daichi HIKIMOTO , Craig M Neville , Cathryn A Sundback
IPC: G01N33/50
CPC classification number: G01N33/5088 , G01N33/5029 , G01N33/5064
Abstract: The present disclosure provides a blood vessel model including: a pair of channel members, mutually opposing each other, each of which includes an opposing face in which a respective microchannel is formed; and a porous membrane that includes plural through-holes penetrating in a thickness direction, that is disposed between the opposing faces of the pair of channel members, and that partitions between the microchannels, wherein the porous membrane is provided with a vascular endothelial cell layer so as to cover one face facing one of the microchannels, an average opening diameter of the through-holes is from 1 μm to 20 μm, and an opening coverage ratio of the through-holes is from 30% to 70%.
-
公开(公告)号:US20240279613A1
公开(公告)日:2024-08-22
申请号:US18645071
申请日:2024-04-24
Applicant: FUJIFILM Corporation
Inventor: Nao YAMAZAKI , Shinji MIMA , Yuki IMAKURA
IPC: C12N5/071
CPC classification number: C12N5/0676 , C12N2501/15 , C12N2501/415 , C12N2501/42 , C12N2501/727 , C12N2501/999 , C12N2503/02 , C12N2506/23
Abstract: An object of the present invention is to provide a method of producing an enteroendocrine cell by using an intestinal stem cell induced from a pluripotent stem cell, a method of analyzing a disease mechanism, an evaluation method for a test substance, a screening method for a therapeutic drug for a digestive system disease, an enteroendocrine cell derived from a pluripotent stem cell, a culture medium or a culture medium kit, and a kit for producing an enteroendocrine cell. According to the present invention, there is provided a method of producing an enteroendocrine cell, the method including an intestinal stem cell or an intestinal epithelial cell, which is induced from a pluripotent stem cell, by using a culture medium that substantially does not contain a ligand of an epidermal growth factor but contains a cAMP activator and a DNA methyltransferase inhibitor.
-
公开(公告)号:US20220267704A1
公开(公告)日:2022-08-25
申请号:US17742123
申请日:2022-05-11
Applicant: FUJIFILM Corporation
Inventor: Izumi OGURA , Keiji SHIGESADA , Shinji MIMA , Yuki IMAKURA , Shun GOTO , Nao YAMAZAKI
Abstract: An object of the present invention is to provide a transportation instrument and a transportation method that enable transportation by using a cell culture container as it is. Further, an object of the present invention is to provide a transportation instrument and a transportation method that enable supply of oxygen required for respiration of cells. Further, an object of the present invention is to provide a transportation instrument and a transportation method that enable suppression of migration of a culture medium into and out of cells caused by the influence of an increase in internal pressure with respect to the temperature during transportation. According to the present invention, provided is a cell preservation or transportation instrument including a plurality of cell storage containers, a plate which has a plurality of recesses for holding the plurality of cell storage containers therein, and a flexible material sheet which seals upper opening portions of the plurality of cell storage containers and upper side wall portions formed by side walls of the recesses of the plate and allows ventilation between an inside and an outside of the plurality of cell storage containers.
-
公开(公告)号:US20240302353A1
公开(公告)日:2024-09-12
申请号:US18666937
申请日:2024-05-17
Applicant: FUJIFILM Corporation
Inventor: Nao YAMAZAKI , Keiji SHIGESADA , Akira WAKABAYASHI , Shinji MIMA , Yuki IMAKURA
CPC classification number: G01N33/5082 , C12M23/16 , C12M23/24 , C12M25/04 , C12M29/06 , C12N5/0679 , C12N2502/70
Abstract: An object of the present invention is to provide a cell culture device capable of reproducing, in vitro, a growth and proliferation environment of an anaerobic bacterium in a living body; a kit for cell culture; and a cell culture method. According to the present invention, there is provided a cell culture device including a plate having a concave portion for accommodating a culture medium, a cell accommodating container having a gas permeable membrane, a first member for holding the cell accommodating container, and a second member having a structure for regulating a gas concentration in an upper space of the cell accommodating container, in which, in a case where a cell sheet is formed on an upper surface of the gas permeable membrane, a space above the gas permeable membrane is in a sealed state in which gas does not pass through.
-
公开(公告)号:US20200095531A1
公开(公告)日:2020-03-26
申请号:US16695073
申请日:2019-11-25
Applicant: FUJIFILM CORPORATION
Inventor: Masafumi NISHINO , Koju ITO , Shinji MIMA , Hayato MIYOSHI
Abstract: Provided is a method for producing a cell laminate including cell layers on both surfaces of a porous membrane, using a vessel having a bottom portion and a side wall portion standing from a periphery of the bottom portion, the porous membrane, and a holding member configured to hold the porous membrane such that the porous membrane faces an inner bottom surface of the vessel and is held at a position that does not contact the inner bottom surface, the method including culturing first cells in a liquid medium that contacts the inner bottom surface of the vessel and a surface of the porous membrane, in a state in which the porous membrane is held, by the holding member, at a position that does not contact the inner bottom surface of the vessel so as to face the inner bottom surface, and in which the bottom portion of the vessel is positioned at the upper side while the porous membrane is positioned at the lower side in a direction of gravity; and culturing the first cells at a lower surface of the porous membrane and culturing second cells at an upper surface of the porous membrane, in a state in which the porous membrane is held, by the holding member, at a position that does not contact the inner bottom surface of the vessel so as to face the inner bottom surface, and in which the bottom portion of the vessel is positioned at the lower side while the porous membrane is positioned at the upper side in the direction of gravity.
-
公开(公告)号:US20210147808A1
公开(公告)日:2021-05-20
申请号:US17158797
申请日:2021-01-26
Applicant: FUJIFILM Corporation
Inventor: Shinji MIMA , Yuki IMAKURA , Izumi OGURA
IPC: C12N5/071
Abstract: An object of the present invention is to provide a method for producing an intestinal epithelial cell in which the barrier function is maintained while the differentiation of a pluripotent stem cell into a liver cell is suppressed and an intestinal epithelial cell in which the barrier function is maintained while the differentiation into a liver cell is suppressed. According to the present invention, provided is the method for producing an intestinal epithelial cell, including a step 1 of differentiating a pluripotent stem cell into an intestinal stem cell and a step 2 of differentiating the intestinal stem cell obtained in the step 1 into an intestinal epithelial cell in a presence of one or more selected from the group consisting of a MEK1 inhibitor, a DNA methylation inhibitor, and a TGFβ receptor inhibitor, and EGF, in which during the step 2, a cell under differentiation is replated one or more times at the predetermined timing which is defined in the present specification.
-
公开(公告)号:US20180243214A1
公开(公告)日:2018-08-30
申请号:US15967970
申请日:2018-05-01
Applicant: FUJIFILM Corporation
Inventor: Tsukasa KITAHASHI , Shinji MIMA , Takeshi MATSUMOTO , Takahiro SEKIGUCHI , Mikinaga MORI
IPC: A61K9/127 , A61K31/7068 , A61K31/337 , A61K47/28 , A61K47/24 , A61P35/00
CPC classification number: A61K9/127 , A61K31/337 , A61K31/7068 , A61K47/24 , A61K47/28 , A61P35/00 , A61K2300/00
Abstract: An object of the present invention is to provide a tumor therapeutic agent and a kit which have superior antitumor effects as compared with gemcitabine, a taxane antitumor agent, and a combination therapy thereof which have been put on the market. According to the present invention, there is provided a tumor therapeutic agent obtained by combining a taxane antitumor agent with a liposome composition in which gemcitabine or a salt thereof is contained in a liposome.
-
公开(公告)号:US20210275453A1
公开(公告)日:2021-09-09
申请号:US17184928
申请日:2021-02-25
Applicant: FUJIFILM Corporation
Inventor: Tsukasa KITAHASHI , Shinji MIMA , Takeshi MATSUMOTO , Takahiro SEKIGUCHI , Mikinaga MORI
IPC: A61K9/127 , A61K47/24 , A61K47/28 , A61K31/337 , A61K31/7068 , A61P35/00
Abstract: An object of the present invention is to provide a tumor therapeutic agent and a kit which have superior antitumor effects as compared with gemcitabine, a taxane antitumor agent, and a combination therapy thereof which have been put on the market. According to the present invention, there is provided a tumor therapeutic agent obtained by combining a taxane antitumor agent with a liposome composition in which gemcitabine or a salt thereof is contained in a liposome.
-
公开(公告)号:US20190192546A1
公开(公告)日:2019-06-27
申请号:US16286930
申请日:2019-02-27
Applicant: FUJIFILM Corporation
Inventor: Yoshihide IWAKI , Tsukasa KITAHASHI , Shinji MIMA
IPC: A61K31/7068 , A61K31/337 , A61P35/00 , A61K47/42
CPC classification number: A61K31/7068 , A61K9/14 , A61K31/337 , A61K47/42 , A61P35/00 , A61P43/00
Abstract: An object of the present invention is to provide an anti-tumor agent and an anti-tumor kit which have superior anti-tumor effect as compared with a therapy with gemcitabine, paclitaxel or a combination thereof; as well as an anti-tumor effect enhancer. According to the present invention, provided is an anti-tumor agent including paclitaxel or a salt thereof and 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine or a salt or prodrug thereof.
-
-
-
-
-
-
-
-
-